Asia Pacific Platelet Aggregation Devices Market to grow at a CAGR of 26.3% during 2016 to 2021
- Advertising -
The Asia Pacific Platelet Aggregation Devices Market was worth USD 25.6 million in 2016 and is estimated to be growing at a CAGR of 26.3%, to reach USD 82.27 million by 2021. Platelets are a type of blood cells whose major function is to form blood clots at the site of injuries.
They are responsible to achieve homeostasis and they also play an important role in inflammation. The process of clumping together of blood platelets to form blood clots is called platelet aggregation.
- Advertising -
Browse Market data tables and in-depth TOC of the Asia Pacific Platelet Aggregation Devices Market to 2021 at www.marketdataforecast.com/market-…ices-market-3546/
In the case of platelet disorders, platelet count in the blood changes and clot formation do not occur properly. Platelet aggregation tests are performed before conducting a surgery for any abnormalities and platelet aggregation devices are used to control the aggregation process to stop bleeding.
Constant advancements in technology to improve aggregators, increasing platelet disorders, growing number of cardiovascular surgeries and increase in geriatric population are the major factors driving the growth of platelet aggregation devices market. Lack of adequately trained professionals and unaffordable cost of devices are restraining the growth of the market.
The Asia Pacific market for platelet aggregation devices is segmented by product, applications, end user and by region. Based on product, the market is segmented into systems, reagents and consumables and accessories.
Platelet aggregation systems hold the largest market share due to the increasing automation of aggregation testing procedures. Based on application, the market is segmented into clinical applications and research applications.
Clinical applications are again segmented into cardiovascular applications, orthopedic applications and other clinical applications. Clinical applications segment holds the largest market share due to the increased adoption of aggregator devices by healthcare professionals.
Based on end user, the market is segmented into standalone hospitals, diagnostic laboratories, research and academic institutes and other end users. Standalone hospitals are expected to hold the largest market share in end users segment due to the increase in platelet disorders and increasing use of platelet therapy for cancer patients.
Asia Pacific market is geographically segmented into China, India, Japan, Australia and South Korea. Asia-Pacific is projected to be the fastest growing market segment.
It is due to the huge population base and increasing adoption of latest technologies in this region.
Key players in the Asia Pacific platelet aggregation devices market are Helena Laboratories Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Accriva Diagnostics, Sentinel CH. S.p.A., Bio/Data Corporation, Tem Group and Aggredyne, Inc.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: